Monthly Communication Report

Corporation:	Sandoz Canada Inc.
Associated registration:	768899-234283-36
Communication date:	2026-05-27
Posted date:	2026-06-01

Designated Public Office Holders who participated in the communication:	Justine Frame, Conseillère en politiques Cabinet du ministre, Health Canada (HC) Sandenga Yeba, Directeur des politiques et chef de cabinet adjoint Cabinet du ministre de la Santé, Health Canada (HC)
List of Details Subject matter Detail Budget, Economic Development, Health "In line with current government priorities, ensure greater harmonisation of policies from the Departments of Innovation, Science and Economic Development and Health Canada's regulatory efficiency and streamlining efforts with regard to drug regulation and approval, particularly under the Food and Drugs Act for pharmaceutical products offered for sale in Canada. The objective is to make quality generic and biosimilar medicines available more quickly in Canada, in the interests of patients and the provinces and territories, while generating substantial savings for private and public plans."
Responsible Officer who filed this communication report:	Michel Robidoux
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.